Strategic Advisors LLC Has $1.53 Million Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Strategic Advisors LLC cut its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 14.6% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 19,557 shares of the company’s stock after selling 3,349 shares during the period. Strategic Advisors LLC’s holdings in GE HealthCare Technologies were worth $1,529,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of GEHC. Good Life Advisors LLC acquired a new position in shares of GE HealthCare Technologies during the third quarter worth $461,000. Global Retirement Partners LLC increased its holdings in shares of GE HealthCare Technologies by 1.9% during the third quarter. Global Retirement Partners LLC now owns 11,219 shares of the company’s stock worth $1,053,000 after buying an additional 205 shares in the last quarter. Bleakley Financial Group LLC increased its holdings in shares of GE HealthCare Technologies by 7.2% during the third quarter. Bleakley Financial Group LLC now owns 16,495 shares of the company’s stock worth $1,548,000 after buying an additional 1,114 shares in the last quarter. Trust Co. of Vermont increased its holdings in shares of GE HealthCare Technologies by 5.2% during the third quarter. Trust Co. of Vermont now owns 3,342 shares of the company’s stock worth $314,000 after buying an additional 165 shares in the last quarter. Finally, Moss Adams Wealth Advisors LLC acquired a new position in shares of GE HealthCare Technologies during the third quarter worth $274,000. 82.06% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on the stock. Citigroup upped their price target on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a report on Thursday. Wells Fargo & Company increased their price objective on GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a report on Friday. Finally, Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and increased their price objective for the company from $95.00 to $103.00 in a report on Wednesday, January 8th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $97.67.

GE HealthCare Technologies Stock Performance

Shares of GE HealthCare Technologies stock opened at $92.21 on Monday. The company has a current ratio of 1.23, a quick ratio of 0.98 and a debt-to-equity ratio of 1.12. The business has a 50-day moving average price of $84.03 and a two-hundred day moving average price of $85.54. GE HealthCare Technologies Inc. has a 1-year low of $74.51 and a 1-year high of $94.80. The company has a market cap of $42.13 billion, a P/E ratio of 25.33, a PEG ratio of 2.93 and a beta of 1.15.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.26 by $0.19. The company had revenue of $5.32 billion for the quarter, compared to analysts’ expectations of $5.33 billion. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. As a group, analysts anticipate that GE HealthCare Technologies Inc. will post 4.3 EPS for the current year.

GE HealthCare Technologies Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, February 14th. Stockholders of record on Tuesday, January 14th were given a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.15%. The ex-dividend date of this dividend was Tuesday, January 14th. This is a boost from GE HealthCare Technologies’s previous quarterly dividend of $0.03. GE HealthCare Technologies’s dividend payout ratio is 3.85%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.